Target intelligence / Profile preview

DNA-directed RNA polymerases I, II, and III subunit RPABC1 (POLR2E)

Target
POLR2E
Molecular classification
Enzyme, Transcription factor (structural, as pol II machinery component)
01

Overview

DNA-directed RNA polymerases I, II, and III subunit RPABC1 (POLR2E) encodes the fifth largest subunit shared among the three major eukaryotic DNA-dependent RNA polymerases (I, II, III), all of which are responsible for transcribing cellular DNA into various classes of RNA. This subunit is crucial in the RNA polymerase II complex and forms part of the lower jaw surrounding the central cleft to help guide the incoming DNA template. Its activity includes mRNA synthesis and production of ribosomal and small non-coding RNAs, underlining its fundamental role in gene expression. POLR2E participates in interactions with viral and cellular transactivators, and is present in excess relative to other polymerase subunits. Genetic variation and dysregulation of POLR2E have been associated with disease states such as prostate cancer. No approved drugs act directly and specifically on POLR2E, though some general RNA polymerase inhibitors may act on complexes containing this subunit[1][6][4].

Other names
RNA polymerase II subunit EDNA-directed RNA polymerase II 23 kDa polypeptideDNA-directed RNA polymerase II subunit ERNA polymerases I, II, and III subunit ABC1RPB5 homologPolymerase (RNA) II (DNA directed) polypeptide E, 25kDaDNA-directed RNA polymerase subunit RPABC1hRPB25hsRPB5XAP4
02

Mechanism of action

No drugs specifically target POLR2E; for polymerase inhibitors: block RNA synthesis by inhibiting polymerase activity

03

Biological functions

Transcription of DNA into RNAMessenger RNA (mRNA) synthesis in eukaryotesTranscription initiation and promoter clearanceSynthesis of ribosomal RNA precursors and functional non-coding RNAs including tRNAs and small RNAsMediator of transcriptional activator interactions
04

Disease associations

Cancer (notably prostate cancer)Other (Potential involvement/association with viral transactivators)

Beyond the preview

Go deeper on DNA-directed RNA polymerases I, II, and III subunit RPABC1 (POLR2E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerases I, II, and III subunit RPABC1 (POLR2E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call